Breaking boundaries: Exploring extended pembrolizumab in first-line treatment of renal cell carcinoma with axitinib-pembrolizumab combinationC. Aydogdu, Jozefina Casuscelli, Rafał Stelmach et al.|European Urology|2024Cited by 0